Sphingosine-1-phosphate signaling in Leishmania donovani infection in macrophages

Autor: Shams Tabrez, Farha Naz, Abdur Rub, Mohd Arish, Mohammad Zulfazal Ahmad, Atahar Husein, Rahat Ali
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Leishmania Donovani
Physiology
Gene Expression
Biochemistry
White Blood Cells
chemistry.chemical_compound
0302 clinical medicine
Sphingosine
Animal Cells
Immune Physiology
Medicine and Health Sciences
Post-Translational Modification
Phosphorylation
Extracellular Signal-Regulated MAP Kinases
S1PR2
Protozoans
Leishmania
S1PR3
Innate Immune System
biology
Chemistry
lcsh:Public aspects of medicine
Eukaryota
Cell biology
Receptors
Lysosphingolipid

Infectious Diseases
Sphingosine kinase 1
030220 oncology & carcinogenesis
Cytokines
Cellular Types
Research Article
lcsh:Arctic medicine. Tropical medicine
lcsh:RC955-962
Immune Cells
p38 mitogen-activated protein kinases
Immunology
Leishmania donovani
Cell Line
03 medical and health sciences
parasitic diseases
Parasitic Diseases
Genetics
Animals
Sphingosine-1-phosphate
Secretion
Blood Cells
Macrophages
Organisms
Public Health
Environmental and Occupational Health

Biology and Life Sciences
Proteins
lcsh:RA1-1270
Cell Biology
Molecular Development
biology.organism_classification
Parasitic Protozoans
030104 developmental biology
Gene Expression Regulation
Immune System
biology.protein
Lysophospholipids
Physiological Processes
Developmental Biology
Zdroj: PLoS Neglected Tropical Diseases, Vol 12, Iss 8, p e0006647 (2018)
PLoS Neglected Tropical Diseases
ISSN: 1935-2735
1935-2727
Popis: Background Sphingosine-1-phosphate (S1P) is a crucial regulator of a wide array of cellular processes, such as apoptosis, cell proliferation, migration, and differentiation, but its role in Leishmania donovani infection is unknown. Methodology/ principal findings In the present study, we observed that L. donovani infection in THP-1 derived macrophages (TDM) leads to decrease in the expression of S1pr2 and S1pr3 at mRNA level. We further observed that Leishmania infection inhibits the phosphorylation of sphingosine kinase 1 (sphK1) in a time-dependent manner. Exogenous S1P supplementation decreases L. donovani induced ERK1/2 phosphorylation and increases p38 phosphorylation in TDM, resulting in a decrease in the intracellular parasite burden in a dose-dependent manner. On the other hand, sphK inhibition by DMS increases ERK1/2 phosphorylation leading to increased IL-10 and parasite load. To gain further insight, cytokines expression were checked in S1P supplemented TDM and we observed increase in IL-12, while decrease IL-10 expression at mRNA and protein levels. In addition, treatment of antagonist of S1PR2 and S1PR3 such as JTE-013 and CAY10444 respectively enhanced Leishmania-induced ERK1/2 phosphorylation and parasite load. Conclusions Our overall study not only reports the significant role of S1P signaling during L. donovani infection but also provides a novel platform for the development of new drugs against Leishmaniasis.
Author summary Leishmania donovani is an intracellular parasite which is internalized by host macrophages by subverting several intracellular signaling events. During infection suppression of p38 MAPK and activation of ERK1/2 MAPK have been acclaimed for survival and proliferation of these protozoan parasites. In this study, we show novel signaling pathways that interact with these MAPK that further contributes to determine the final fate of the disease. Sphingosine-1-Phosphate (S1P) is a bioactive lipid that binds to a family of G-protein coupled receptors known as S1P receptors. TDM infected with Leishmania donovani showed a decrease in the expression of S1PR1-3. Moreover, the enzyme that catalyzes S1P production, Sphingosine Kinase 1, showed decreased activation in a time-dependent fashion in infected cells. Furthermore, exogenously supplementation of S1P clears intracellular parasite burden by a decrease in ERK1/2 phosphorylation and IL-10 at mRNA and protein level. On the other hand, S1P induces anti-leishmanial response by activating p38 phosphorylation and IL-12 at mRNA as well as at protein level. To further gain insight on the receptors subtypes involved in the anti-leishmanial response, we specifically blocked S1PR2 and S1PR3. In this study, we found a tremendous increase in the parasite load as a result of increased IL-10 secretion and ERK1/2 phosphorylation on combination of these inhibitor doses. Taking together, our study thus suggested the possible involvement of S1PR2-3 during Leishmania donovani infection in human macrophages. These findings thus elaborate our knowledge in understanding the interaction of signaling intermediates during Leishmania infection which may lead to the discovery of novel therapeutic interventions.
Databáze: OpenAIRE